On “Psychological Factors Affecting a Physical Condition”

Ketterer, Mark W.

doi:10.1016/s0033-3182(91)72057-4

Cited by 8 publications

(3 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Among those with negative/nominal results, treatment of the emotional distress can be expected to decrease angina, psychosocial/occupational disability, and inappropriate health system utilization (Cannon et al, 1994;Klimes et aL, 1990) and may prevent evolution of acute cardiac disease in some of these patients (Haines et aL, 1987;Kawachi et al, 1994a, b). Among those with positive results, treatment of emotional distress can be expected to decrease morbidity and mortality (Ketterer, 1993) and should also diminish inappropriate health care utilization (Allison et al, 1995;Ketterer et al, 1994a), although the pertinent mechanisms remain in debate (Frank and Smith, 1990;Lown, 1987;Kamarck and Jennings, 1991;Ketterer, 1991;Maercklein, 1991, 1992). Future work in this area should be directed toward identifying cost-efficient means of screening angiographic patients for emotional distress.…”

Section: Discussionmentioning

confidence: 99%

Emotional distress among males with “Syndrome X”

et al. 1996

Self Cite

View full text Add to dashboard Cite

The present study examined traditional risk factors and various indices of emotional distress in males with positive angiograms (N = 122), "syndrome X" males with negative or nominal results on angiogram (N = 53), and age- and socioeconomic status-matched males with no manifest history of otherosclerotic disease (N = 56). Syndrome X patients reported more depression on the Ketterer Stress Symptom Frequency Checklist (KSSFC) than positive angiographic patients. And compared with healthy controls, they were more likely to be perceived by a spouse/friend as depressed and anxious on the KSSFC, scored higher on the Framingham Type A Scale, and reported more unprovoked nocturnal awakening. Syndrome X patients generally appear to be similar to patients with positive angiograms with regard to traditional risk factor history but are more distressed than healthy controls. This becomes most evident when denial is circumvented by discussion with significant others or inquiries are "framed" appropriately.

show abstract

Section: Discussionmentioning

confidence: 99%

Emotional distress among males with “Syndrome X”

et al. 1996

Self Cite

View full text Add to dashboard Cite

show abstract

“…It is difficult to see how such an effect can occur unless chronic emotional arousal is invoked (Frank & Smith, 1990; Kamarck & Jennings, 1991;Ketterer, 1991;Lown, 1987), although the mechanisms may involve malignant psychobehavioral influences uncontrolled in this study rather than direct psychoneuroendocrine pathways (Ketterer, 1991). One such mechanism may be treatment-seeking delay (Barsky et al, 1991;Kenyon et al, 1991).…”

Section: Denial Of Depression and Cadmentioning

confidence: 93%

“…While the psychoneuroendocrine and psychobehavioral mechanisms relating psychosocial/emotional stress to chronic and acute ischemic heart disease are under continuing investigation (Frank & Smith, 1990; Kamarck & Jennings, 1991;Ketterer, 1991;Lown, 1987), most epidemiological investigations of psychosocial risk factors have focused on the aggravation, irritation, anger and impatience I'AIAI') of the Type A Behavior Pattern (Dembroski, MacDougall, Costa, & Grandits, 1989;Friedman, 1988).…”

mentioning

confidence: 99%

Denial of Depression as an Independent Correlate of Coronary Artery Disease

Ketterer¹,

Kenyon²,

Foley³

et al. 1996

J Health Psychol

Self Cite

View full text Add to dashboard Cite

A number of psychosocial measures were tested as correlates of coronary artery disease (CAD) in 122 males with positive coronary angiograms and 56 males with no manifest history of atherosclerotic disease who were selected to approximate the patients' age and socio economic status. Only denial of depression as indexed by spouse/friend-minus-self scores on the Ketterer Stress Symptom Frequency Checklist and number of unprovoked nocturnal awakenings were independently and positively related to CAD severity in multivariate regression analyses which controlled for jointly associated cardiac risk factors and commonly used cardiovascular medications. Denial of depression and unprovoked nocturnal awakening appear to be independent correlates of coronary artery disease.

show abstract

Vinyl homo/copolymerization of norbornene and ethylene using sterically enhanced 1,2‐bis(arylimino)acenaphthene–palladium precatalysts

Zeng

Mahmood

Zhang

et al. 2018

J. Polym. Sci. Part A: Polym. Chem.

View full text Add to dashboard Cite

A family of unsymmetrical 1,2-bis(imino)acenaphthene-palladium methyl chloride complexes [1-[2,6-{(C 6 H 5 ) 2 CH} 2 -4-{C(CH 3 ) 3 }-C 6 H 2 N]-2-(ArN)C 2 C 10 H 6 ]PdMeCl (Ar 5 2,6-Me 2 Ph Pd1, 2,6-Et 2 Ph Pd2, 2,6-i Pr 2 Ph Pd3, 2,4,6-Me 3 Ph Pd4, 2,6-Et 2 -4-MePh Pd5) have been prepared and fully characterized by 1 H/ 13 C NMR, FTIR spectroscopies, and elemental analysis. X-ray diffraction analysis of Pd2 complex revealed a square planar geometry. Upon activation with methylaluminoxane, all the palladium complexes displayed high activities for norbornene (NBE) homo-polymerization producing insoluble polymer. For the copolymerization of NBE with ethylene, Pd4 complex exhibited good activities with high incorporation of ethylene (up to 59.2-77.4%) and the resultant copolymer showed high molecular weights as maximum as 150.5 kg mol 21 . V C 2018 Wiley Periodicals, Inc. J. Polym. Sci., Part A: Polym. Chem. 2018, 56, 922-930

show abstract

On “Psychological Factors Affecting a Physical Condition”

Cited by 8 publications

References 14 publications

Emotional distress among males with “Syndrome X”

Emotional distress among males with “Syndrome X”

Denial of Depression as an Independent Correlate of Coronary Artery Disease

Vinyl homo/copolymerization of norbornene and ethylene using sterically enhanced 1,2‐bis(arylimino)acenaphthene–palladium precatalysts

Contact Info

Product

Resources

About